DGAP-News: Novavax, Inc. / Novavax to Report First Quarter Financial Results on May 7, 2014 01.05.2014 / 17:51 --------------------------------------------------------------------- GAITHERSBURG, Md., 2014-05-01 17:51 CEST (GLOBE NEWSWIRE) -- Novavax, Inc. (Nasdaq:NVAX) announced today that it will report its first quarter 2014 financial results on Wednesday, May 7, 2014 after the close of the U.S. financial markets. Following the earnings release, company management will host a conference call and webcast to provide a corporate update and discuss its first quarter 2014 financial results. Details to access the conference call are as follows: Date: Wednesday, May 7, 2014 Time: 4:30 p.m. ET. Call-in numbers: (877) 212-6076 (domestic) or (707) 287-9331 (international) Webcast: www.novavax.com, via 'Investor Info / Events' tab A replay of the conference call will be available from 7:30 pm on May 7, 2014 until midnight June 7, 2014. To access the replay by telephone, dial 1 (855) 859-2056 (domestic) or 1 (404) 537-3406 (international) and use passcode 34845350. The replay will also be available as a webcast and can be found on the 'Investor Info / Events' tab on the Novavax website. About Novavax Novavax, Inc. (Nasdaq:NVAX) is a clinical-stage biopharmaceutical company creating novel vaccines and vaccine adjuvants to address a broad range of infectious diseases worldwide. Using innovative proprietary recombinant protein nanoparticle vaccine technology, the company produces vaccine candidates to efficiently and effectively respond to both known and newly emergent diseases. Additional information about Novavax is available on the company's website, novavax.com. CONTACT: Barclay Phillips SVP, Chief Financial Officer and Treasurer Novavax, Inc. 240-268-2000 News Source: NASDAQ OMX End of Corporate News --------------------------------------------------------------------- 01.05.2014 Dissemination of a Corporate News, transmitted by DGAP - a company of EQS Group AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------- Language: English Company: Novavax, Inc. United States ISIN: US6700021040 End of News DGAP News-Service --------------------------------------------------------------------- 266067 01.05.2014
DGAP-News: Novavax to Report First Quarter Financial Results on May 7, 2014
| Source: EQS Group AG